section name header

General Reference

Nejm 2002;347:589; 346:23, 1990;323:1161

Pathophys and Cause

Cause:

Pathophys:

(Nejm 2002;346:23) Relapsing type very similar to TTP and assoc w circulating very large vonW factor multimers, but predominant renal involvement (Nejm 1991;325:426). Diarrhea-associated types show a shiga toxin-induced thrombogenesis and vasculitis, with 4 systems involved: kidney, skin, joints, bowel

Tissue plasminogen activator is elevated (Nejm 1993;327:755) because is complexed and inactivated

Drug-induced types probably due to drug-induced antibodies

Epidemiology

Increasing incidence; most under age 5 yr where now incidence = 6/100 000; day care clusters occurring. 65% of all types are postinfectious

Signs and Symptoms

Sx:

Diarrhea (86%), vomiting (75%), bloody diarrhea (59%), abdominal cramps (50%), fever (49%), seizures (17%)

Postinfectious type may have a h/o viral or bacterial infection 1-2 wk before

Si:As above; oligo/anuria

Course

2-wk average; <5% mortality if supported; ie, is self-limited

Complications

Renal failure, 47% require dialysis temporarily and 25+% have long-term renal impairment (Jama 2003;290:1360); shock, cardiac arrest, blindness, CVAs

Lab and Xray

Lab:

Chem:Elevated BUN and creatinine

Hem:Crit <30%; microangiopathic picture with red cell fragments, platelets <150 000; if wbc's >15 000, prognosis worse. VonW factor cleaving protease function normal (unlike TTP) (Nejm 1998;379:1578). Elevated D-dimer

Urine:Hematuria, proteinuria

Treatment

Rx:

(Nejm 1991;325:398)

Prevent by avoiding antibiotic rx of O157 E. colidiarrhea (Nejm 2000;342:1930 vs Jama 2002;288:996), and antimotility drugs

Supportive; dialysis; steroids may help by decreasing edema; plasma exchange transfusions help (Am J Med 1999;107:573)

No help: antihistamines, anti-shiga toxin (Jama 2003;290:1337)